TY - JOUR
T1 - Preanalytic influence of sample handling on SELDI-TOF serum protein profiles
AU - Timms, John F.
AU - Arslan-Low, Elif
AU - Gentry-Maharaj, Aleksandra
AU - Luo, Zhiyuan
AU - T'Jampens, Davy
AU - Podust, Vladimir N.
AU - Ford, Jeremy
AU - Fung, Eric T.
AU - Gammerman, Alex
AU - Jacobs, Ian
AU - Menon, Usha
PY - 2007/4
Y1 - 2007/4
N2 - Background: High-throughput proteomic methods for disease biomarker discovery in human serum are promising, but concerns exist regarding reproducibility of results and variability introduced by sample handling. This study investigated the influence of different preanalytic handling methods on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) protein profiles of prefractionated serum. We investigated whether older collections with longer sample transit times yield useful protein profiles, and sought to establish the most feasible collection methods for future clinical proteomic studies. Methods: To examine the effect of tube type, clotting time, transport/incubation time, temperature, and storage method on protein profiles, we used 6 different handling methods to collect sera from 25 healthy volunteers. We used a high-throughput, prefractionation strategy to generate anion-exchange fractions and examined their protein profiles on CM10, IMAC30-Cu, and 1150 arrays by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Results: Prolonged transport and incubation at room temperature generated low mass peaks, resulting in distinctions among the protocols. The most and least stringent methods gave the lowest overall peak variances, indicating that proteolysis in the latter may have been nearly complete. For samples transported on ice there was little effect of clotting time, storage method, or transit time. Certain proteins (TTR, ApoCI, and transferrin) were unaffected by handling, but others (ITIH4 and hemoglobin β) displayed significant variability. Conclusions: Changes in preanalytical handling variables affect profiles of serum proteins, including proposed disease biomarkers. Proteomic analysis of samples from serum banks collected using less stringent protocols is applicable if all samples are handled identically. © 2007 American Association for Clinical Chemistry.
AB - Background: High-throughput proteomic methods for disease biomarker discovery in human serum are promising, but concerns exist regarding reproducibility of results and variability introduced by sample handling. This study investigated the influence of different preanalytic handling methods on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) protein profiles of prefractionated serum. We investigated whether older collections with longer sample transit times yield useful protein profiles, and sought to establish the most feasible collection methods for future clinical proteomic studies. Methods: To examine the effect of tube type, clotting time, transport/incubation time, temperature, and storage method on protein profiles, we used 6 different handling methods to collect sera from 25 healthy volunteers. We used a high-throughput, prefractionation strategy to generate anion-exchange fractions and examined their protein profiles on CM10, IMAC30-Cu, and 1150 arrays by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Results: Prolonged transport and incubation at room temperature generated low mass peaks, resulting in distinctions among the protocols. The most and least stringent methods gave the lowest overall peak variances, indicating that proteolysis in the latter may have been nearly complete. For samples transported on ice there was little effect of clotting time, storage method, or transit time. Certain proteins (TTR, ApoCI, and transferrin) were unaffected by handling, but others (ITIH4 and hemoglobin β) displayed significant variability. Conclusions: Changes in preanalytical handling variables affect profiles of serum proteins, including proposed disease biomarkers. Proteomic analysis of samples from serum banks collected using less stringent protocols is applicable if all samples are handled identically. © 2007 American Association for Clinical Chemistry.
U2 - 10.1373/clinchem.2006.080101
DO - 10.1373/clinchem.2006.080101
M3 - Article
C2 - 17303688
SN - 0009-9147
VL - 53
SP - 645
EP - 656
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 4
ER -